Nuwellis Selected as a Recipient of the Governor’s International Trade Award
“We are honored to be recognized as a recipient of the Governor’s International Trade Award,” said Nestor Jaramillo, Jr., president and CEO of Nuwellis. “We can attribute this success to our hardworking, diverse employees, who – even during a pandemic – continue to educate hospitals and providers on the benefits of using the Aquadex SmartFlow® System to treat fluid-overloaded adult and pediatric patients weighing 20 kg or more in
Nuwellis is a medical device company that develops, manufactures, and commercializes the Aquadex SmartFlow® System for ultrafiltration therapy, an effective treatment option for fluid overloaded critical care, heart failure and pediatric patients. Nuwellis has increased employment in
“This year’s award winners are among many companies based in
Nuwellis currently conducts business in the
Nuwellis was one of five companies honored in the awards, recognized in the service category for small to medium-sized companies (less than 500 employees). Award recipients were celebrated at a ceremony on
About the Aquadex SmartFlow System
The Aquadex SmartFlow system delivers clinically proven therapy using a simple, flexible and predictable method of removing excess fluid from patients suffering from hypervolemia (fluid overload). The Aquadex SmartFlow system is indicated for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kg or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered by a health care provider, within an outpatient or inpatient clinical setting, under physician prescription, both having received training in extracorporeal therapies.
Laurel HoodHealth+Commerce email@example.com
Source: Nuwellis, Inc.